HeartBeam, Inc.
HeartBeam, Inc. (BEATW) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for HeartBeam, Inc. (BEATW), featuring income statements, balance sheets, and cash flow data.
HeartBeam, Inc. (BEATW) Income Statement & Financial Overview
Access detailed annual and quarterly income data for HeartBeam, Inc. BEATW financial performance.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $2.89M | $2.84M | $2.43M | $2.010M |
| SG&A Expenses | $2.18M | $2.25M | $2.36M | $2.10M |
| Operating Expenses | $5.07M | $5.09M | $4.78M | $4.11M |
| Total Costs & Expenses | $5.07M | $5.09M | $4.78M | $4.11M |
| Interest Income | $96000.00 | $134000.00 | $178000.00 | $230000.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $20000.00 |
| Depreciation & Amortization | $0.00 | $5.09M | $4.78M | $4.11M |
| EBITDA | -$5.07M | -$5.09M | $0.00 | -$3.86M |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$5.07M | -$5.09M | -$4.78M | -$4.11M |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | $90000.00 | $134000.00 | $178000.00 | $230000.00 |
| Income Before Tax | -$4.98M | -$4.96M | -$4.61M | -$3.88M |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | $0.00 | -$5.09M | -$4.78M | -$4109.00 |
| Net Income | -$4.98M | -$4.96M | -$4.61M | -$3.88M |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$0.19 | -$0.19 | -$0.17 | -$0.15 |
| Diluted EPS | -$0.19 | -$0.19 | -$0.17 | -$0.15 |
| Weighted Avg Shares Outstanding | $26.75M | $26.57M | $26.51M | $26.33M |
| Weighted Avg Shares Outstanding (Diluted) | $26.75M | $26.57M | $26.51M | $26.33M |
Financial performance has remained strong, with revenue growing from $0.00 in Q4 2023 to $0.00 in Q3 2024. Gross profit continued to perform well, with margins at N/A in the latest quarter. Operating income reached -$5.07M in Q3 2024, holding a steady N/A margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$5.07M. Net income dropped to -$4.98M, keeping EPS at -$0.19. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan